-

07:42:09 AM

Latest LLY Stock Market News

LLY - Lilly(Eli) & Co

09/21/21 4:15 PM

NYSE : LLY

Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.5 Billion Combined Aggregate Principal Amount of Its Outstanding Debt Securities

Eli Lilly and Company (NYSE: LLY) announced today the pricing terms of its previously announced cash tender offer for specified series of its outstanding debt securities.Holders of notes subject to the tender offer who validly tendered, and did not

RHEA-AI

neutral

09/21/21 1:37 PM

NYSE : LLY

covid-19

Lilly announces procurement agreement with European Commission to supply bamlanivimab and etesevimab together for the treatment of confirmed COVID-19

Eli Lilly and Company (NYSE: LLY) today announced a Joint Procurement Agreement with the European Commission (EC) to supply up to 220,000 doses of bamlanivimab and etesevimab for the treatment of confirmed COVID-19 in patients aged 12 years and older who

RHEA-AI

neutral

09/21/21 7:00 AM

NYSE : LLY

Lilly Announces the Early Tender Results of Its Pending Cash Tender Offer for Up to $1.5 Billion Combined Aggregate Principal Amount of Its Outstanding Debt Securities and Removal of the Note Caps for Its 3.950% Notes due 2049 and Its 4.150% Notes due 2059

Eli Lilly and Company (NYSE: LLY) announced today the early tender results of its previously announced cash tender offer for specified series of its outstanding debt securities. Lilly also announced that it has removed the previously announced note caps

RHEA-AI

neutral

09/16/21 3:56 PM

NYSE : LLY

covid-19

Emergency Use Authorization for Lilly's bamlanivimab and etesevimab administered together expanded to include post-exposure prophylaxis for COVID-19

The U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab 700 mg and etesevimab 1400 mg administered together to include post-exposure prophylaxis (PEP) in certain individuals for the prevention of

RHEA-AI

negative

09/15/21 6:45 AM

NYSE : LLY

covid-19

Lilly to supply 388,000 doses of etesevimab to U.S. government for treatment of COVID-19

Eli Lilly and Company (NYSE: LLY) today announced an additional purchase by the U.S. government for its neutralizing antibody therapies authorized for emergency use as a treatment for COVID-19. As part of the agreement, Lilly will supply 388,000 doses of

RHEA-AI

negative

09/13/21 10:00 AM

NYSE : LLY

conferences

Lilly to Participate in the 2021 Cantor Virtual Global Healthcare Conference

Eli Lilly and Company (NYSE: LLY) will participate in the 2021 Cantor Virtual Global Healthcare Conference on Tuesday, September 28, 2021. Patrik Jonsson, senior vice president, president of Lilly Immunology and Lilly USA, and chief customer

RHEA-AI

neutral

09/13/21 8:00 AM

NYSE : LLY

conferences

Lilly to Present New Data from Oncology Portfolio at ESMO Congress

New data from various studies of Eli Lilly and Company's (NYSE: LLY) Verzenio ® (abemaciclib), Retevmo ® (selpercatinib) and CYRAMZA ® (ramucirumab) will be presented at the European Society for Medical Oncology (ESMO) Congress 2021, to be held virtually

RHEA-AI

neutral

09/09/21 2:00 PM

NYSE : LLY

Lilly Prices First Sustainability Bond to Advance Global ESG Strategy

Eli Lilly and Company (NYSE: LLY) today announced the pricing of its first sustainability bond to advance its global environmental, social and governance (ESG) strategy to increase access to medicines, improve lives and communities, empower a diverse

RHEA-AI

positive

09/09/21 8:00 AM

NYSE : LLY

FDA grants Jardiance® Breakthrough Therapy designation for heart failure with preserved ejection fraction

The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for Jardiance ® (empagliflozin) as an investigational treatment for adults with heart failure with preserved ejection fraction (HFpEF), Boehringer

RHEA-AI

positive

09/07/21 9:00 AM

NYSE : LLY

Lilly Diabetes joins The Leona M. and Harry B. Helmsley Charitable Trust to pledge significant funding to "Type 1 Diabetes Camps Initiative"

Lilly Diabetes will commit nearly $1 million over the next three years in a joint effort with The Leona M. and Harry B. Helmsley Charitable Trust to promote greater access to care and resources and to inspire confidence for children living with type 1

RHEA-AI

very positive

1 2 3 4 5 6 7 8 9 10 Next

LLY Data:

IndustryPharmaceutical Preparation Manufacturing
Websitewww.lilly.com
CeoDavid Ricks
Security nameLilly(Eli) & Co
Issue typecs
SectorManufacturing
Sic code2834
Employees2020
Tags
- Health Technology
- Pharmaceuticals: Major
- Manufacturing
- Pharmaceutical Preparation Manufacturing
AddressLilly Corporate Ctr
StateIndiana
CityIndianapolis
Zip46285-0001
CountryUS
Phone13172762000

LLY Description:

Lilly is a global health care leader that unites caring with discovery to create medicines that make life better for people around the world. It was founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today it remains true to that mission in all its work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.